Risk factors for the development of recurrent atrial fibrillation: Role of pacing and clinical variables
Authors:
- Gervasio A. LamasGLGervasio A. Lamas
- Catherine O. CantillonCCCatherine O. Cantillon
- Elliott M. AntmanEAElliott M. Antman
- 1 June 1995
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 129 (6) , 1127-1132
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillationThe American Journal of Cardiology, 1993
- Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: The hidden benefits of dual-chamber pacingJACC, 1992
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugsJACC, 1990
- Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortalityAmerican Heart Journal, 1988
- Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atriumThe American Journal of Cardiology, 1987
- Response of atrial fibrillation to therapy: Role of etiology and left atrial diameterJournal of Electrocardiology, 1980
- Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood.Circulation, 1978
- Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversionClinical Pharmacology & Therapeutics, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958